PLASMINOGEN-ACTIVATOR INHIBITOR-1 MESSENGER-RNA IS EXPRESSED IN PLATELETS AND MEGAKARYOCYTES AND THE MEGAKARYOBLASTIC CELL-LINE CHRF-288

被引:45
作者
KONKLE, BA [1 ]
SCHICK, PK [1 ]
HE, XL [1 ]
LIU, RJ [1 ]
MAZUR, EM [1 ]
机构
[1] ST MARYS HOSP, WATERBURY, CT USA
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1993年 / 13卷 / 05期
关键词
PLASMINOGEN ACTIVATOR INHIBITOR-1; PLATELETS; MEGAKARYOCYTES; FIBRINOLYSIS;
D O I
10.1161/01.ATV.13.5.669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is present in the platelet alpha-granule and is released on platelet activation. Platelet PAI-1 could either be synthesized by the megakaryocyte or taken up from the plasma. In this report we confirm the presence of PAI-1 protein in human megakaryocytes by Western blot analysis and show its synthesis in guinea pig megakaryocytes by metabolic labeling. We document the presence of PAI-1 mRNA in human platelets and show a 3-kb mRNA species on Northern blot analysis of guinea pig megakaryocytes. Neither untreated CHRF-288 cells, a megakaryoyblastic cell line, nor human erythroleukemia (HEL) cells expressed PAI-1 mRNA. Phorbol ester (phorbol 12-myristate 13-acetate, 160 nM) treatment of CHRF-288 and HEL cells for 4 days induced PAI-1 mRNA expression in CHR F-288 cells but not in HEL cells. These studies show that PAI-1 is synthesized by megakaryocytes. Megakaryocytes most likely determine the PAI-1 content of platelets and thereby establish the antifibrinolytic potential of the platelet.
引用
收藏
页码:669 / 674
页数:6
相关论文
共 50 条
[1]   VITRONECTIN BINDS TO ACTIVATED HUMAN PLATELETS AND PLAYS A ROLE IN PLATELET-AGGREGATION [J].
ASCH, E ;
PODACK, E .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1372-1378
[2]   PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS [J].
BOOTH, NA ;
SIMPSON, AJ ;
CROLL, A ;
BENNETT, B ;
MACGREGOR, IR .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) :327-333
[3]  
BOSMA PJ, 1991, J BIOL CHEM, V266, P17845
[4]   PRESENCE OF FUNCTIONALLY ACTIVE TISSUE PLASMINOGEN-ACTIVATOR IN HUMAN CFU-M DERIVED MEGAKARYOCYTES INVITRO [J].
BRISSONJEANNEAU, C ;
SOLBERG, LA ;
SULTAN, Y .
FIBRINOLYSIS, 1990, 4 (02) :107-115
[5]  
DECLERCK PJ, 1988, BLOOD, V71, P220
[6]   DETECTION AND PARTIAL CHARACTERIZATION OF AN INHIBITOR OF PLASMINOGEN-ACTIVATOR IN HUMAN-PLATELETS [J].
ERICKSON, LA ;
GINSBERG, MH ;
LOSKUTOFF, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) :1465-1472
[7]   PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR - PURIFICATION AND CHARACTERIZATION OF INTERACTION WITH PLASMINOGEN ACTIVATORS AND ACTIVATED PROTEIN-C [J].
FAY, WP ;
OWEN, WG .
BIOCHEMISTRY, 1989, 28 (14) :5773-5778
[8]   BRIEF REPORT - COMPLETE DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 DUE TO A FRAME-SHIFT MUTATION [J].
FAY, WP ;
SHAPIRO, AD ;
SHIH, JL ;
SCHLEEF, RR ;
GINSBURG, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1729-1733
[9]  
FUGMAN DA, 1990, BLOOD, V75, P1252
[10]  
GEORGE JN, 1990, BLOOD, V76, P859